Analysis of Vital Signs in Patients With COVID-19

Respiratory Disease Clinical Trial

Official title:

Analysis of Vital Signs in Patients With COVID-19

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04927078
• Other study ID #: 287454
• Status: Completed
• Start date: April 1, 2020
• Est. completion date: October 31, 2020

Study information

• Verified date: June 2021
• Source: Oxehealth Limited
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This project will use data obtained from a proprietary vision-based patient monitoring and management system (OxeVision) for measuring heart rate and respiratory rate which is in clinical use at the Coventry and Warwickshire Partnership NHS Trust.

Description:

The investigators will analyse data from patients with known COVID 19 infection both during, and where possible before clinical COVID 19 infection and controls to determine whether changes can be detected in these parameters that precede overt clinical deterioration. The role of remote vision-based patient monitoring and management in supporting the care of patients with COVID-19 will be assessed through staff interviews.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: October 31, 2020
• Est. primary completion date: October 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients age 18 and above. Patients on wards with a medical diagnosis of COVID 19 who are in rooms with the Vision based patient monitoring and management system.

Exclusion Criteria:

Children will be excluded. No data will be excluded unless specifically requested by the treating clinician.

Related Conditions & MeSH terms

• Respiration Disorders
• Respiratory Disease
• Respiratory Tract Diseases

Intervention

Other:
• Observation of breathing pattern
Observations will be collected using a remote vision based patient monitoring and management system.

Locations

Country	Name	City	State
United Kingdom	Coventry and Warwickshire Partnership NHS	Coventry

Sponsors (2)

Lead Sponsor	Collaborator
Oxehealth Limited	Royal Brompton & Harefield NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Breathing rates	Breathing rates collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.	Data will be collected throughout study completion, an average of 7 months, to obtain breathing rate before and after the diagnosis of COVID 19.
Secondary	Pulse rates	Pulse rate collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.	Data will be collected throughout study completion, an average of 7 months, to obtain pulse rate before and after the diagnosis of COVID 19.
Secondary	BR and PR	Similar data to be collected from control subjects	Data will be collected throughout study completion, an average of 7 months, to obtain breathing and pulse rate before and after the diagnosis of COVID 19.